Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SIRAJ K AHMED MD INC

NPI: 1396282406 · MANTECA, CA 95336 · Pulmonary Disease Physician · NPI assigned 01/26/2017

$1.20M
Total Medicaid Paid
36,238
Total Claims
17,613
Beneficiaries
27
Codes Billed
2018-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWOLF, JACOB (CREDENTIALING DEPARTMENT)
NPI Enumeration Date01/26/2017

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,105 $59K
2019 2,190 $64K
2020 3,794 $111K
2021 6,548 $196K
2022 8,953 $264K
2023 4,885 $220K
2024 7,763 $288K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99232 Subsequent hospital care, per day, moderate complexity 12,362 1,321 $293K
99233 Prolong inpt eval add15 m 5,495 1,311 $169K
95800 647 247 $96K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,432 2,107 $88K
94060 1,664 1,658 $72K
94726 1,241 1,240 $61K
94729 1,236 1,235 $61K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 854 684 $56K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 655 652 $49K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 445 145 $42K
94618 1,291 1,285 $41K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 856 831 $35K
99205 Prolong outpt/office vis 340 340 $30K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,306 734 $26K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,980 918 $20K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 669 654 $16K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 346 299 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 183 165 $10K
99223 Prolong inpt eval add15 m 132 130 $7K
99000 1,582 1,431 $6K
94003 332 53 $5K
99254 26 26 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 31 31 $2K
99406 50 50 $609.93
94010 34 18 $369.00
94664 13 13 $91.73
94760 36 35 $12.30